SanghaviMRutherfordJD. Cardiovascular physiology of pregnancy. Circulation2014; 130: 1003–1008.
2.
NamaVAntoniosTFOnwudeJ. Mid-trimester blood pressure drop in normal pregnancy: Myth or reality?J Hypertens2011; 29: 763–768.
3.
GaillardRBakkerRWillemsenSP. Blood pressure tracking during pregnancy and the risk of gestational hypertensive disorders: The Generation R Study. Eur Heart J2011; 32: 3088–3097.
4.
BouthoornSHGaillardRSteegersEA. Ethnic differences in blood pressure and hypertensive complications during pregnancy: The Generation R study. Hypertension2012; 60: 198–205.
5.
GundersonEPJacobsDRJr.ChiangV. Childbearing is associated with higher incidence of the metabolic syndrome among women of reproductive age controlling for measurements before pregnancy: The CARDIA study. Am J Obstet Gynecol2009; 201: 177.e1–9–177.e1–9.
6.
HanleyAJMcKeown-EyssenGHarrisSB. Association of parity with risk of type 2 diabetes and related metabolic disorders. Diabetes Care2002; 25: 690–695.
7.
ColditzGAWillettWCStampferMJ. A prospective study of age at menarche, parity, age at first birth, and coronary heart disease in women. Am J Epidemiol1987; 126: 961–970.
8.
LawlorDAEmbersonJREbrahimS. Is the association between parity and coronary heart disease due to biological effects of pregnancy or adverse lifestyle risk factors associated with child-rearing? Findings from the British Women’s Heart and Health Study and the British Regional Heart Study. Circulation2003; 107: 1260–1264.
Kritz-SilversteinDBarrett-ConnorEWingardDL. Relation of pregnancy history to insulin levels in older, nondiabetic women. Am J Epidemiol1994; 140: 375–382.
11.
ErqouSKaptogeSPerryPL. Emerging Risk Factor Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke and nonvascular mortality. JAMA2009; 302: 412–423.
12.
GundersonEPLewisCEWeiGS. Lactation and changes in maternal metabolic risk factors. Obstet Gynecol2007; 109: 729–738.
13.
GundersonEPJacobsDRJr.ChiangV. Duration of lactation and incidence of the metabolic syndrome in women of reproductive age according to gestational diabetes mellitus status: A 20-year prospective study in CARDIA (Coronary Artery Risk Development in Young Adults). Diabetes2010; 59: 495–504.
14.
LeeSYKimMTJeeSH. Does long-term lactation protect premenopausal women against hypertension risk? A Korean women’s cohort study. Prev Med2005; 41: 433–438.
15.
StuebeAMSchwarzEBGrewenK. Duration of lactation and incidence of maternal hypertension: A longitudinal cohort study. Am J Epidemiol2011; 174: 1147–1158.
16.
VillegasRGaoYTYangG. Duration of breast-feeding and the incidence of type 2 diabetes mellitus in the Shanghai Women’s Health Study. Diabetologia2008; 51: 258–266.
17.
StuebeAMRich-EdwardsJWWillettWC. Duration of lactation and incidence of type 2 diabetes. JAMA2005; 294: 2601–2610.
18.
AuneDNoratTRomundstadP. Breastfeeding and the maternal risk of type 2 diabetes: A systematic review and dose–response meta-analysis of cohort studies. Nutr Metab Cardiovasc Dis2014; 24: 107–115.
19.
JagerSJacobsSKrogerJ. Breast-feeding and maternal risk of type 2 diabetes: A prospective study and meta-analysis. Diabetologia2014; 57: 1355–1365.
20.
OnatAKayaAŞimş ekB. Underlying autoimmune activation rendering paradoxical non-linear relationship between biomarkers and cardiometabolic risk. J Clin Cell Immunol2016; 7: 1–1.
21.
ErikssonJGKajantieEThornburgK. Prenatal and maternal characteristics and later risk for coronary heart disease in women. Eur J Prev Cardiol2016; 23: 385–390.
22.
Peters SAE, van der Schouw YT, Wood AM, et al. Parity, breastfeeding and risk of coronary heart disease: A pan-European case-cohort study. Eur J Prev Cardiol. 2006; 23: 1755–1765.
OnatACanGÖrnekE. Increased apolipoprotein A-I levels mediate the development of prehypertension. Anadolu Kardiyol Derg.2013; 13: 306–314.
25.
OnatACanG. Enhanced proinflammatory state and autoimmune activation: A breakthrough to understanding chronic diseases. Curr Pharm Design2014; 20: 575–584.
26.
KimHRLeeSAKimHJ. Elevated levels of macrophage migration inhibitory factor in women with metabolic syndrome. Hormone Metab Res2011; 43: 642–645.
27.
TodrosTBontempoSPiccoliE. Increased levels of macrophage migration inhibitory factor (MIF) in preeclampsia. Eur Obst Gynecol Reprod Biol2005; 123: 162–166.
28.
CardaropoliSIettaFRomagnoliR. Lower macrophage migration inhibitory factor concentrations in maternal serum before pre-eclampsia onset. J Interferon Cytokine Res2014; 34: 537–542.
29.
MoraSKamstrupPRRifaiN. Lipoprotein(a) and risk of type 2 diabetes. Clin Chem2010; 56: 1252–1260.
